Anthony Doyle, Chief Financial Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 54,000 shares at $4.08 ($220K) on 2020-08-11, disclosed to the SEC on 2020-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BCRX | BUY | 2021-11-24 | $880K | — | Filing → |